Eurizon Capital SGR S.p.A. Invests $1.79 Million in Docusign Inc. $DOCU

Eurizon Capital SGR S.p.A. acquired a new position in shares of Docusign Inc. (NASDAQ:DOCU) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 26,131 shares of the company’s stock, valued at approximately $1,790,000.

A number of other institutional investors also recently made changes to their positions in DOCU. Hillsdale Investment Management Inc. bought a new position in Docusign during the fourth quarter worth about $882,000. Fideuram Asset Management Ireland dac bought a new position in Docusign during the fourth quarter worth about $722,000. National Pension Service increased its position in Docusign by 184.5% during the fourth quarter. National Pension Service now owns 61,797 shares of the company’s stock worth $4,227,000 after acquiring an additional 40,072 shares during the period. Basepoint Wealth LLC bought a new position in Docusign during the fourth quarter worth about $39,000. Finally, Rothschild Investment LLC increased its position in Docusign by 1,650.0% during the fourth quarter. Rothschild Investment LLC now owns 2,415 shares of the company’s stock worth $165,000 after acquiring an additional 2,277 shares during the period. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at Docusign

In other Docusign news, Director Mary Agnes Wilderotter sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $48.15, for a total transaction of $144,450.00. Following the completion of the transaction, the director directly owned 59,803 shares in the company, valued at $2,879,514.45. The trade was a 4.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $46.84, for a total transaction of $281,040.00. Following the transaction, the executive owned 79,233 shares of the company’s stock, valued at approximately $3,711,273.72. This represents a 7.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 65,489 shares of company stock valued at $3,124,693. 0.59% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Weiss Ratings lowered shares of Docusign from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, April 15th. Citizens Jmp cut their price target on Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a research note on Wednesday, March 18th. Wells Fargo & Company cut their price target on Docusign from $75.00 to $60.00 and set an “equal weight” rating for the company in a research note on Wednesday, March 18th. Royal Bank Of Canada cut their price target on Docusign from $70.00 to $55.00 and set a “sector perform” rating for the company in a research note on Wednesday, March 18th. Finally, Robert W. Baird cut their price target on Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $61.40.

Docusign Trading Down 3.4%

Shares of DOCU stock opened at $55.10 on Wednesday. The stock has a market cap of $10.71 billion, a P/E ratio of 37.23, a price-to-earnings-growth ratio of 2.17 and a beta of 0.92. The stock has a 50 day simple moving average of $47.41 and a 200 day simple moving average of $54.53. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $94.67.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06. The business had revenue of $836.86 million during the quarter, compared to analysts’ expectations of $828.23 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.86 earnings per share. Analysts forecast that Docusign Inc. will post 1.76 EPS for the current year.

Docusign declared that its Board of Directors has approved a stock repurchase plan on Tuesday, March 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to repurchase up to 21% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s board of directors believes its shares are undervalued.

Trending Headlines about Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign announced its app is now available in ChatGPT and Codex, extending its Intelligent Agreement Management platform into OpenAI products and potentially boosting adoption by making it easier for customers to create, analyze, and manage agreements with natural-language prompts. Docusign Brings Trusted Agreement Intelligence and Workflows into ChatGPT and Codex
• Positive Sentiment: The company also named Graham Sheldon as Chief Product Officer, a move aimed at accelerating its AI-focused product strategy and strengthening execution around its Intelligent Agreement Management vision. Docusign Appoints Graham Sheldon as Chief Product Officer to Accelerate Intelligent Agreement Management Vision
• Neutral Sentiment: Several directors disclosed stock sales, including Anna Marrs, James A. Beer, and Teresa Briggs. The transactions were relatively small and were executed under pre-arranged Rule 10b5-1 plans, which usually makes them less concerning for investors. SEC filing: Anna Marrs Form 4
• Neutral Sentiment: Investor attention is also focused on Docusign’s June 4 earnings report, with recent commentary suggesting the market wants proof that its AI-driven product strategy is translating into stronger execution. Dear Docusign Stock Fans, Mark Your Calendars for June 4

Docusign Company Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.